Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Oxandrolone is an androgenic hormone used to treat muscle loss from prolonged corticosteroid treatment and to treat bone pain associated with osteoporosis.
- Mechanism
- Curator reviewed
Oxandrolones interact with androgen receptors in target tissues.
- Primary indication
- Use to promote weight gain after weight loss following extensive surgery.Curator reviewed · 3 structured indications
- Formula / weight
- C19H30O3 · 306.4397 g/mol (avg)
- First approval
- United States, 2005
- Code names
- CB 8075 · NSC-67068 · SC-11585
- Brand names
- Oxandrin
Resolves to
Clinical / RWD
Structure
InChIKey
QSLJIVKCVHQPLV-PEMPUTJUSA-NSMILES[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CC[C@@]2([H])CC(=O)OC[C@]12CTargets
What you can answer from here — as of September 23, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Oxandrolone, and which of those have an active Phase 3 trial?